Nada Khudair
Qatar University, Qatar
Title: Non-ionic Surfactant Vesicles as Delivery System for Letrozole
Biography
Biography: Nada Khudair
Abstract
Aromatase is an enzyme that leads the bioconversion of androgen into estrogen, which is a main source for cell proliferation and growth in hormone dependent breast cancer. Letrozole (LTZ) is a third generation potent aromatase inhibitor that is approved by the Food and Drug Administration (FDA) for the management of hormone positive breast cancer. The current formulation (Femara®) lacks an effective bioavailability due to LTZ poor-water solubility and rapid systemic metabolism.